(TechInvest) – EMVision Medical Devices (ASX: EMV) has commenced a world-first pre-hospital study of its First Responder Brain Scanner, placing the company at the forefront of next-generation stroke care innovation.
The trial will evaluate the scanner’s performance and integration within a Mobile Stroke Unit in Melbourne — one of just 45 such units worldwide. The two-stage study is being run in partnership with the Australian Stroke Alliance, Ambulance Victoria, and the Royal Melbourne Hospital. Stage 1 will assess usability, workflow, and safety in the Mobile Stroke Unit environment. CONTINUE